These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36414796)

  • 1. Clinical characteristics, risk factors, and outcomes in Chilean triple negative breast cancer patients: a real-world study.
    Acevedo F; Walbaum B; Medina L; Merino T; Camus M; Puschel K; Ramírez K; Manzor M; Veglia P; Martinez R; Guerra C; Navarro M; Bauerle C; Dominguez F; Sánchez C
    Breast Cancer Res Treat; 2023 Jan; 197(2):449-459. PubMed ID: 36414796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic disparities in young patients based on breast cancer subtype: A population-based study from the SEER database.
    Chen B; Zhang X; Liu Y; Wang C
    Medicine (Baltimore); 2023 Mar; 102(13):e33416. PubMed ID: 37000095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of male triple negative breast cancer: A population-based study.
    Ghani S; Sochat M; Luo J; Tao Y; Ademuyiwa F
    Breast J; 2020 Sep; 26(9):1748-1755. PubMed ID: 32856383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screen-detected breast cancer is associated with better prognosis and survival compared to self-detected/symptomatic cases in a Chilean cohort of female patients.
    Walbaum B; Puschel K; Medina L; Merino T; Camus M; Razmilic D; Navarro ME; Dominguez F; Cordova-Delgado M; Pinto MP; Acevedo F; Sánchez C
    Breast Cancer Res Treat; 2021 Sep; 189(2):561-569. PubMed ID: 34244869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of Triple-Negative Breast Cancers (TNBC) Compared with Non-TNBC: Does the Survival Vary for All Stages?
    Agarwal G; Nanda G; Lal P; Mishra A; Agarwal A; Agrawal V; Krishnani N
    World J Surg; 2016 Jun; 40(6):1362-72. PubMed ID: 26842691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Detection Method and Age on Survival Outcomes in Triple-Negative Breast Cancer: A Population-Based Cohort Analysis.
    Rayson D; Payne JI; Michael JCR; Tsuruda KM; Abdolell M; Barnes PJ
    Clin Breast Cancer; 2018 Oct; 18(5):e955-e960. PubMed ID: 29885790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast conserving surgery (BCS) with adjuvant radiation therapy showed improved prognosis compared with mastectomy for early staged triple negative breast cancer patients Running title: BCS had better prognosis than mastectomy for early TNBC patients.
    Wang SE; Sun YD; Zhao SJ; Wei F; Yang G
    Math Biosci Eng; 2019 Sep; 17(1):92-104. PubMed ID: 31731341
    [No Abstract]   [Full Text] [Related]  

  • 8. Determinants of Prognosis in Triple-Negative Breast Cancer: Report from a Large Breast Cancer Registry.
    Tahmasebi S; Almayali AMJ; Arasteh P; Akrami M; Zangouri V; Arasteh P; Hosseini SM; Salehi Nobandegani A; Asgari A; Sadeghi E; Zahiri L; Talei A
    Arch Iran Med; 2021 Apr; 24(4):280-288. PubMed ID: 34196187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Racial/Ethnic Differences in Treatment and Mortality Among Women With Triple-Negative Breast Cancer.
    Cho B; Han Y; Lian M; Colditz GA; Weber JD; Ma C; Liu Y
    JAMA Oncol; 2021 Jul; 7(7):1016-1023. PubMed ID: 33983438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of outcomes between metaplastic and triple-negative breast cancer patients.
    Polamraju P; Haque W; Cao K; Verma V; Schwartz M; Klimberg VS; Hatch S; Niravath P; Butler EB; Teh BS
    Breast; 2020 Feb; 49():8-16. PubMed ID: 31675684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neighborhood and racial influences on triple negative breast cancer: evidence from Northeast Ohio.
    Eom KY; Berg KA; Joseph NE; Runner K; Tarabichi Y; Khiyami A; Perzynski AT; Sossey-Alaoui K
    Breast Cancer Res Treat; 2023 Apr; 198(2):369-381. PubMed ID: 36781520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparisons of Oncologic Outcomes between Triple-Negative Breast Cancer (TNBC) and Non-TNBC among Patients Treated with Breast-Conserving Therapy.
    Kim S; Park HS; Kim JY; Ryu J; Park S; Kim SI
    Yonsei Med J; 2016 Sep; 57(5):1192-8. PubMed ID: 27401651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triple-negative breast cancers: Are they always different from nontriple-negative breast cancers? An experience from a tertiary center in India.
    ; Parshad R; Kazi M; Seenu V; Mathur S; Dattagupta S; Haresh KP
    Indian J Cancer; 2017; 54(4):658-663. PubMed ID: 30082553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active behavior of triple-negative breast cancer with adipose tissue invasion: a single center and retrospective review.
    Yamaguchi J; Moriuchi H; Ueda T; Kawashita Y; Hazeyama T; Tateishi M; Aoki S; Uchihashi K; Nakamura M
    BMC Cancer; 2021 Apr; 21(1):434. PubMed ID: 33879104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathological Patterns and Outcomes of Triple-Positive Versus Triple-Negative Breast Cancer: A Retrospective Study at a Tertiary Cancer Center.
    Kadi MS; Alhebshi AH; Shabkah AA; Alzahrani WA; Enani GN; Samkari AA; Iskanderani O; Saleem AM; Farsi AH; Trabulsi NH
    Cureus; 2023 Jul; 15(7):e42389. PubMed ID: 37621828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis in different subtypes of metaplastic breast cancer: a population-based analysis.
    He X; Ji J; Dong R; Liu H; Dai X; Wang C; Esteva FJ; Yeung SJ
    Breast Cancer Res Treat; 2019 Jan; 173(2):329-341. PubMed ID: 30341462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opportunities for improving triple-negative breast cancer outcomes: results of a population-based study.
    Rapiti E; Pinaud K; Chappuis PO; Viassolo V; Ayme A; Neyroud-Caspar I; Usel M; Bouchardy C
    Cancer Med; 2017 Mar; 6(3):526-536. PubMed ID: 28211614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases.
    Anders CK; Deal AM; Miller CR; Khorram C; Meng H; Burrows E; Livasy C; Fritchie K; Ewend MG; Perou CM; Carey LA
    Cancer; 2011 Apr; 117(8):1602-11. PubMed ID: 21472708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 14-gene B-cell immune signature in early-stage triple-negative breast cancer (TNBC): a pooled analysis of seven studies.
    Conte B; Brasó-Maristany F; Hernández AR; Pascual T; Villacampa G; Schettini F; Vidal Losada MJ; Seguí E; Angelats L; Garcia-Fructuoso I; Gómez-Bravo R; Lorman-Carbó N; Paré L; Marín-Aguilera M; Martínez-Sáez O; Adamo B; Sanfeliu E; Fratini B; Falato C; Chic N; Vivancos A; Villagrasa P; Staaf J; Parker JS; Perou CM; Prat A
    EBioMedicine; 2024 Apr; 102():105043. PubMed ID: 38447275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic Syndrome: does this influence breast cancer outcomes in the triple-negative population?
    Kennard K; Buckley ME; Sizer LM; Larson S; Carter WB; Frazier TG; Carp NZ
    Breast Cancer Res Treat; 2021 Feb; 186(1):53-63. PubMed ID: 33389405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.